Randomized Trial to Evaluate Therapeutic Gain by Changing Chemoradiotherapy From Concurrent-Adjuvant to Induction-Concurrent Sequence, and Radiotherapy From Conventional to Accelerated Fractionation for Advanced Nasopharyngeal Carcinoma.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 10 Aug 2018
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary) ; Fluorouracil (Primary)
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 03 Aug 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 30 Mar 2015 Planned End Date changed from 1 May 2017 to 1 Dec 2017 as reported by ClinicalTrials.gov record.
- 20 Mar 2015 Planned End Date changed from 1 Apr 2017 to 1 May 2017 as reported by ClinicalTrials.gov record.